SecurityDVA / DaVita HealthCare Partners Inc.
InstitutionBridgewater Associates, LP
ManagerRay Dalio, Bob Prince
Shares0
Value $ 0
Related 23918KAQ1 / DaVita HealthCare Partners Inc. 5.125% Bond due 2024-07-15
23918KAP3 / Davita Inc 5.75% 08/15/22
23918KAL2 / Davita Inc. 6.375% 11/01/18
23918KAM0 / Davita Inc. 6.625% 11/01/20

Bridgewater Associates, LP closes position in DVA / DaVita HealthCare Partners Inc.

August 13, 2018 - Bridgewater Associates, LP has filed a 13F-HR form disclosing ownership of 0 shares of DaVita HealthCare Partners Inc. (NYSE:DVA) with total holdings valued at $0 USD as of June 30, 2018. Bridgewater Associates, LP had filed a previous 13F-HR on May 15, 2018 disclosing 223,124 shares of DaVita HealthCare Partners Inc. at a value of $14,713,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.

Other investors with closed positions include Clinton Group Inc, Balyasny Asset Management Llc, Highbridge Capital Management Llc, Maverick Capital Ltd, and Nomura Holdings Inc.

DaVita HealthCare Partners Inc. has declared a standard industrial code (sic) of 809 which is the "Miscellaneous Health And Allied Services, Not" industry. Bridgewater Associates, LP's top industries are "Printing, Publishing, And Allied Industries" (sic 27), "Rubber And Miscellaneous Plastics Products" (sic 30), and "Stone, Clay, Glass, And Concrete Products" (sic 32).

Bridgewater Associates, LP closes  position in DVA / DaVita HealthCare Partners Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR DAVITA COM 23918K108 0 -100.00 0 -100.00 -14,713 0
2018-03-31 13F-HR DAVITA COM 23918K108 223,124 14,713 14,713 0
2017-12-31 13F-HR DAVITA COM 23918K108 0 -100.00 0 -100.00 -21,051 0
2017-09-30 13F-HR DAVITA COM 23918K108 62.07 354,456 449.66 21,051 404.09 18,000 -1,125 -26.93
2017-06-30 13F-HR DAVITA COM 23918K108 66.36 64,486 -54.68 4,176 -56.82 -5,164 -332 -3.43
2017-03-31 13F-HR DAVITA COM 23918K108 66.08 142,304 61.26 9,672 70.73 3,572 435 7.67
2016-12-31 13F-HR DAVITA COM 23918K108 65.13 88,244 35.14 5,665 31.32 1,494 -143 -3.32
2016-09-30 13F-HR DAVITA COM 23918K108 71.69 65,300 -14.05 4,314 -26.56 -765 -795 -13.53
2016-06-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 75.33 75,970 1,051.06 5,874 1,113.64 5,225 165 34.01
2016-03-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 71.52 6,600 -79.34 484 -78.27 -1,813 70 3.13
2015-12-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 31,945 0.00 2,227 2,227 0
2015-09-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 0 -100.00 0 -100.00 -6,320 0
2015-06-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 80.38 79,526 43.74 6,320 40.54 1,945 -122 -2.72
2015-03-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 78.51 55,326 10.59 4,497 18.69 416 292 7.70
2014-12-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 74.44 50,026 88.59 3,789 95.31 1,749 100 5.14
2014-09-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 72.73 26,526 -14.70 1,940 -13.74 -333 24 1.05
2014-06-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 70.58 31,098 -52.11 2,249 -49.70 -2,389 167 3.73
2014-03-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 66.11 64,941 -30.50 4,471 -24.49 -1,884 434 7.33
2013-12-31 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 60.14 93,437 4.52 5,921 16.39 243 591 11.62
2013-09-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 88.85 89,400 684.21 5,087 269.43 6,930 -3,220 -233.84
2013-06-30 13F-HR DAVITA HEALTHCARE PARTNERS I COM 23918K108 11,400 1,377

Related SEC Filings

DVA / DaVita HealthCare Partners Inc. / Berkshire Hathaway Inc - SC 13D/A (Activist Investment)

2018-05-11 sec.gov
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (3-7)

DVA / DaVita HealthCare Partners Inc. / Berkshire Hathaway Inc - SC 13D/A (Activist Investment)

2018-05-11 sec.gov
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (3-1)

DVA / DaVita HealthCare Partners Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
davitainc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 7 )*       Name of issuer:  DaVita Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  23918K108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   ( 

DVA / DaVita HealthCare Partners Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
davitainc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 7 )*       Name of issuer:  DaVita Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  23918K108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   ( 

DVA / DaVita HealthCare Partners Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-02-08 sec.gov
us23918k1088_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) DAVITA INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 23918K108 -------------------------------------------------------- (CUSIP Number) December 31, 2017 -------------------------------------------------------- (D

Related News Stories

5 Safe Stocks to Buy With Low Price-to-Book Ratios

2018-10-13 investorplace
In the present volatile stock market, value analysis, is becoming more and more important. When analyzing value stocks, most investors use the P/E ratio to search for lucrative stocks, but there are other ratios that an investor can consider, like the price-to-sales ratio (P/S) and price-to-book (P/B) ratio. The P/S ratio is simply price divided by sales. One of the reasons P/S is a better choice is because it looks at sales rather than earnings like the price-to-earnings ratio.

Thursday’s Biggest Winners and Losers in the S&P 500

2018-09-13 247wallst
September 13, 2018: The S&P 500 closed up 0.5% at 2,904.22. The DJIA closed up 0.6% at 26,146.27. Separately, the Nasdaq was up 0.8% at 8,013.71. (4-1)

Nephros: HemoCleanse Partnership To Deliver Further Upside

2018-09-05 seekingalpha
The subsidiary (“SRP”) recently partnered with HemoCleanse (to develop a carbon-based sorbent technology for the continuous renal replacement therapy). (3-0)

California Dialysis Legislation Pummels DaVita Shares

2018-08-30 247wallst
The state of California has taken the first step to limit the price that dialysis centers will be allowed to charge patients. The state assembly late Wednesday passed the bill, which must now go the state senate for approval and then on to Governor Jerry Brown for signature. Senate passage is expected, but Brown has not indicated what he plans to do when the bill reaches his desk. (3-0)

Interpublic (IPG) Gains on Buyouts, High Debt a Concern

2018-08-22 zacks
The Interpublic Group of Companies, Inc. (IPG - Free Report) possesses a distinctive competitive advantage, courtesy of its digital capabilities, diversified business model and geographic reach. Buyouts and strategic investments continue to act as key growth catalysts for the company. (10-0)



CUSIP: 23918K108